{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:24:27Z","timestamp":1787793867482,"version":"build-2784847793"},"reference-count":74,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T00:00:00Z","timestamp":1637366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Scleroderma-like disorders include a set of entities involving cutis, subcutis and, sometimes, even muscular tissue, caused by several pathogenetic mechanisms responsible for different clinical\u2013pathological pictures. The absence of antinuclear antibodies (ANA), Raynaud\u2019s phenomenon and capillaroscopic anomalies constitutes an important element of differential diagnosis with systemic sclerosis. When scleroderma can be excluded, on the basis of the main body sites, clinical evolution, any associated pathological conditions and specific histological features, it is possible to make a correct diagnosis.<\/jats:p>","DOI":"10.3390\/medicina57111275","type":"journal-article","created":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T21:00:50Z","timestamp":1637528450000},"page":"1275","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical and Histopathological Features of Scleroderma-like Disorders: An Update"],"prefix":"10.3390","volume":"57","author":[{"given":"Rosario","family":"Foti","sequence":"first","affiliation":[{"name":"Division of Reumathology, A.O.U. \u201cPoliclinico-San Marco\u201d, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"De Pasquale","sequence":"additional","affiliation":[{"name":"U.O. Dermatologia, Ospedale San Marco, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylenia","family":"Dal Bosco","sequence":"additional","affiliation":[{"name":"Division of Reumathology, A.O.U. \u201cPoliclinico-San Marco\u201d, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Visalli","sequence":"additional","affiliation":[{"name":"Division of Reumathology, A.O.U. \u201cPoliclinico-San Marco\u201d, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Amato","sequence":"additional","affiliation":[{"name":"Division of Reumathology, A.O.U. \u201cPoliclinico-San Marco\u201d, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Gangemi","sequence":"additional","affiliation":[{"name":"U.O. Anatomia Patologica, Ospedale San Marco, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Foti","sequence":"additional","affiliation":[{"name":"U.O. Dermatologia, Ospedale San Marco, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Ramondetta","sequence":"additional","affiliation":[{"name":"U.O. Dermatologia, Ospedale San Marco, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.clindermatol.2006.07.004","article-title":"Systemic and localized scleroderma","volume":"24","author":"Chung","year":"2006","journal-title":"Clin. Dermatol. Ottobre"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12016-017-8625-4","article-title":"Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders, a Comprehensive Review","volume":"53","author":"Ferreli","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11926-002-0006-0","article-title":"Scleroderma-like cutaneous syndromes","volume":"4","author":"Mori","year":"2002","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.clindermatol.2006.07.011","article-title":"Scleromyxedema","volume":"24","author":"Falasca","year":"2006","journal-title":"Clin. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0190-9622(95)90007-1","article-title":"Scleromyxedema","volume":"33","author":"Dinneen","year":"1995","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.sder.2006.04.001","article-title":"Lichen myxedematosus (papular mucinosis), new concepts and perspectives for an old disease","volume":"25","author":"Rongioletti","year":"2006","journal-title":"Semin. Cutan. Med. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.pcl.2012.03.011","article-title":"Pediatric scleroderma, systemic or localized forms","volume":"59","author":"Torok","year":"2012","journal-title":"Pediatr. Clin. N. Am."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1590\/abd1806-4841.20152890","article-title":"Localized scleroderma, clinical spectrum and therapeutic update","volume":"90","author":"Careta","year":"2015","journal-title":"An. Bras. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1085-5629(98)80064-3","article-title":"Scleroderma-like disorders","volume":"17","author":"Jablonska","year":"1998","journal-title":"Semin. Cutan. Med. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/1346-8138.14160","article-title":"Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis","volume":"45","author":"Jinnin","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_11","first-page":"563","article-title":"Serum aldolase level is a useful indicator of disease activity in eosinophilic fasciitis","volume":"22","author":"Fujimoto","year":"1995","journal-title":"J. Rheumatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.alit.2019.03.001","article-title":"Eosinophilic fasciitis, From pathophysiology to treatment","volume":"68","author":"Ihn","year":"2019","journal-title":"Allergol. Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2133.2004.06062.x","article-title":"Serum levels of tissue inhibitor of metalloproteinase-1 and 2 in patients with eosinophilic fasciitis","volume":"151","author":"Jinnin","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/ard.55.12.935","article-title":"Serum and synovial fluid levels of interleukin-5 in a patient with eosinophilic fasciitis","volume":"55","author":"Nishiya","year":"1996","journal-title":"Ann. Rheum. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/art.1780251111","article-title":"Serum eosinophilotactic activity in eosinophilic fasciitis","volume":"25","author":"Wasserman","year":"1982","journal-title":"Arthritis Rheum."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2214\/ajr.184.1.01840169","article-title":"MRI for diagnosis and monitoring of patients with eosinophilic fasciitis","volume":"184","author":"Baumann","year":"2005","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jaad.2005.06.015","article-title":"Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease, expanding the sclerodermoid spectrum","volume":"53","author":"Schaffer","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.bmt.1703111","article-title":"Chronic graft-versus-host disease, clinical manifestation and therapy","volume":"28","author":"Ratanatharathorn","year":"2001","journal-title":"Bone Marrow Transpl."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/01.bor.0000144760.37777.fa","article-title":"Autoantibodies in systemic sclerosis and fibrosing syndromes, clinical indications and relevance","volume":"16","author":"Cepeda","year":"2004","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/BOR.0000000000000118","article-title":"Scleromyxedema","volume":"26","author":"Hummers","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-0500-7-571","article-title":"Scleredema\u2014An uncommon cause of swelling in a child--a case report and review of the literature","volume":"7","author":"Shrestha","year":"2014","journal-title":"BMC Res. Notes"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1111\/jdv.13272","article-title":"Scleredema. A multicentre study of characteristics, comorbidities, course and therapy in 44 patients","volume":"29","author":"Rongioletti","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ecl.2013.07.004","article-title":"Dermatologic manifestations of diabetes mellitus, a review","volume":"42","author":"Han","year":"2013","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamainternmed.2019.5284","article-title":"Risk of Nephrogenic Systemic Fibrosis in Patients with Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent, A Systematic Review and Meta-analysis","volume":"180","author":"Woolen","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.ki.5002338","article-title":"Gadolinium and nephrogenic systemic fibrosis","volume":"72","author":"Grobner","year":"2007","journal-title":"Kidney Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semarthrit.2005.08.002","article-title":"Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature","volume":"35","author":"Mendoza","year":"2006","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"key":"ref_28","first-page":"96","article-title":"Cutaneous amyloidosis","volume":"9","author":"Borowicz","year":"2011","journal-title":"Skinmed"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3349\/ymj.2006.47.5.737","article-title":"Scleroderma-like manifestation in a patient with primary systemic amyloidosis, response to high-dose intravenous immunoglobulin and plasma exchange","volume":"47","author":"Cho","year":"2006","journal-title":"Yonsei Med. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e8771","DOI":"10.1097\/MD.0000000000008771","article-title":"Case report, One case of primary AL amyloidosis repeatedly misdiagnosed as scleroderma","volume":"96","author":"Sun","year":"2017","journal-title":"Medicine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2340\/00015555-0855","article-title":"Primary localized cutaneous amyloidosis in patients with scleroderma","volume":"90","author":"Kikuchi","year":"2010","journal-title":"Acta Derm. Venereol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/10409238.2014.942450","article-title":"The role of RecQ helicases in non-homologous end-joining","volume":"49","author":"Keijzers","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.arr.2016.03.002","article-title":"Werner syndrome, Clinical features, pathogenesis and potential therapeutic interventions","volume":"33","author":"Oshima","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/humu.20337","article-title":"The spectrum of WRN mutations in Werner syndrome patients","volume":"27","author":"Huang","year":"2006","journal-title":"Hum. Mutat."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1447-0594.2012.00913.x","article-title":"Diagnostic criteria for Werner syndrome based on Japanese nationwide epidemiological survey","volume":"13","author":"Takemoto","year":"2013","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1365-2133.1996.41773.x","article-title":"The scleroatrophic syndrome of Huriez, a cancer-prone genodermatosis","volume":"134","author":"Hamm","year":"1996","journal-title":"Br. J. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1086\/302718","article-title":"A gene for an autosomal dominant scleroatrophic syndrome predisposing to skin cancer (Huriez syndrome) maps to chromosome 4q23","volume":"66","author":"Lee","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000479036","article-title":"A Rare Syndrome Resembling Scleroderma, Huriez Syndrome","volume":"4","author":"Aytekin","year":"2018","journal-title":"Ski. Appendage Disord."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11914-017-0375-y","article-title":"Melorheostosis, a Rare Sclerosing Bone Dysplasia","volume":"15","author":"Kotwal","year":"2017","journal-title":"Curr Osteoporos Rep. agosto"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0899-7071(03)00149-9","article-title":"Melorheostosis with scleroderma","volume":"28","author":"Shivanand","year":"2004","journal-title":"Clin. Imaging"},{"key":"ref_41","first-page":"324","article-title":"Bone dysplasia series. Melorheostosis, review and update","volume":"50","author":"Greenspan","year":"1999","journal-title":"Can. Assoc. Radiol. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00360792","article-title":"Vascular anomalies in association with osteodystrophies\u2014A spectrum","volume":"10","author":"Kessler","year":"1983","journal-title":"Skelet. Radiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2106\/00004623-196345060-00007","article-title":"Melorheostosis. Review of the literature and report of an interesting case with a nineteen-year follow-up","volume":"45","author":"Morris","year":"1963","journal-title":"J. Bone Jt. Surg. Am."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s002560050449","article-title":"Sclerotome distribution of melorheostosis and multicentric fibromatosis","volume":"27","author":"Rhys","year":"1998","journal-title":"Skeletal Radiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1177\/107110070502600814","article-title":"Melorheostosis isolated to the calcaneus, a case report and review of the literature","volume":"26","author":"Woolridge","year":"2005","journal-title":"Foot Ankle Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1468-3083.2006.01619.x","article-title":"Stiff skin syndrome","volume":"20","author":"Geng","year":"2006","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e1282","DOI":"10.1002\/mgg3.1282","article-title":"Acromicric dysplasia with stiff skin syndrome-like severe cutaneous presentation in an 8-year-old boy with a missense FBN1 mutation, Case report and literature review","volume":"8","author":"Wang","year":"2020","journal-title":"Mol. Genet. Genomic. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1525-1470.2002.00029.x","article-title":"Restrictive dermopathy, a case report and a critical review of all hypotheses of its origin","volume":"19","author":"Nijsten","year":"2002","journal-title":"Pediatr. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2340\/00015555-2970","article-title":"Restrictive Dermopathy, Four Case Reports and Structural Skin Changes","volume":"98","author":"Bidier","year":"2018","journal-title":"Acta Derm. Venereol."},{"key":"ref_50","first-page":"1252","article-title":"Vitamin B12-associated localized scleroderma and its treatment","volume":"30","author":"Ho","year":"2004","journal-title":"Dermatol. Surg."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1365-2133.2004.05969.x","article-title":"A case of peplomycin-induced scleroderma","volume":"150","author":"Asano","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1468-3083.2004.01086.x","article-title":"Dermal fibrosis and cutaneous necrosis after recombinant interferon-beta1a injection in a multiple sclerosis patient","volume":"19","author":"Ozden","year":"2005","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0190-9622(00)90233-0","article-title":"Scleroderma-like reaction induced by uracil-tegafur (UFT), a second-generation anticancer agent","volume":"42","author":"Kono","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1067\/mjd.2003.30","article-title":"Scleroderma-like cutaneous lesions induced by paclitaxel, a case study","volume":"48","author":"Kupfer","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2133.2005.06708.x","article-title":"Methysergide-induced scleroderma-like changes of the legs","volume":"153","author":"Kluger","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaad.2001.07.001","article-title":"Gemcitabine-associated scleroderma-like changes of the lower extremities","volume":"51","author":"Bessis","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10067-002-0635-8","article-title":"Diffuse scleroderma occurring after the use of paclitaxel for ovarian cancer","volume":"22","author":"Bugatti","year":"2003","journal-title":"Clin. Rheumatol."},{"key":"ref_58","first-page":"421","article-title":"Autoimmune diseases associated with drugs, chemicals and environmental factors","volume":"112","year":"2000","journal-title":"Toxicol Lett."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/bmj.1.6015.936","article-title":"Immunological mechanisms in the pathogenesis of vinyl chloride disease","volume":"1","author":"Ward","year":"1976","journal-title":"Br Med J"},{"key":"ref_60","first-page":"108","article-title":"Dermatological aspects of so called vinyl chloride monomer disease","volume":"27","author":"Czernielewski","year":"1979","journal-title":"Derm. Beruf. Umwelt."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3810\/pgm.1999.04.691","article-title":"Porphyria cutanea tarda. Don\u2019t forget to look at the urine","volume":"105","author":"Rich","year":"1999","journal-title":"Postgrad. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0741-8329(03)00127-7","article-title":"Iron as a co-morbid factor in nonhemochromatotic liver disease","volume":"30","author":"Bonkovsky","year":"2003","journal-title":"Alcohol"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1013746828074","article-title":"Porphyria cutanea tarda, multiplicity of risk factors including HFE mutations, hepatitis C.; and inherited uroporphyrinogen decarboxylase deficiency","volume":"47","author":"Egger","year":"2002","journal-title":"Dig. Dis. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-0560.1992.tb01557.x","article-title":"Histologic and immunofluorescence study of cutaneous porphyrias","volume":"19","author":"Maynard","year":"1992","journal-title":"J. Cutan. Pathol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/1523-1747.ep12676478","article-title":"The molecular basis of the action of chloroquine in porphyria cutanea tarda","volume":"61","author":"Scholnick","year":"1973","journal-title":"J. Investig. Dermatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0002-9343(79)90403-0","article-title":"Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients","volume":"67","author":"Grossman","year":"1979","journal-title":"Am. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1172\/JCI110423","article-title":"Uroporphyrin I stimulation of collagen biosynthesis in human skin fibroblasts. A unique dark effect of porphyrin","volume":"69","author":"Varigos","year":"1982","journal-title":"J. Clin. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1525-1470.2006.00198.x","article-title":"Progressive sclerodermatous skin changes in a child with phenylketonuria","volume":"23","year":"2006","journal-title":"Pediatr. Dermatol."},{"key":"ref_69","first-page":"73","article-title":"POEMS syndrome revealed by a scleroderma-like skin thickening","volume":"127","author":"Toussaint","year":"2000","journal-title":"Ann. Dermatol. Venereol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome, definitions and long-term outcome","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1182\/asheducation-2005.1.360","article-title":"POEMS Syndrome","volume":"2005","author":"Dispenzieri","year":"2005","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1468-3083.2005.01200.x","article-title":"Multiple myeloma with scleroderma-like changes","volume":"19","author":"Blanco","year":"2005","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2133.2004.06273.x","article-title":"Cutaneous manifestations of the malignant carcinoid syndrome","volume":"152","author":"Bell","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11882-012-0241-z","article-title":"Clinical overview of cutaneous features in hypereosinophilic syndrome","volume":"12","author":"Aigner","year":"2012","journal-title":"Curr. Allergy Asthma. Rep."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/11\/1275\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:33:08Z","timestamp":1760167988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/11\/1275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,20]]},"references-count":74,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["medicina57111275"],"URL":"https:\/\/doi.org\/10.3390\/medicina57111275","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,20]]}}}